论文部分内容阅读
目的观察米非司酮治疗子宫肌瘤的临床疗效。方法选自本院门诊60例符合条件的子宫肌瘤患者,自经期开始的第2天口服米非司酮,1次/d,10 mg/次,于晚饭1 h后服用,3个月为1疗程。B超测定子宫及子宫肌瘤在用药前后的体积,并进行血液检测。结果用药后,子宫及子宫肌瘤明显缩小,且贫血状况得到改善、激素水平下降,但复发率高。结论米非司酮可以作为子宫肌瘤的保守治疗方案。
Objective To observe the clinical efficacy of mifepristone in the treatment of uterine fibroids. METHODS: Sixty patients with uterine fibroids who were eligible were enrolled in this study. Mifepristone was given orally once daily on the second day of the menstrual cycle, once daily for 1 h and then for 1 h after dinner. 1 course of treatment. B-measured uterine and uterine fibroids in the volume before and after treatment, and blood tests. Results After treatment, uterine and uterine fibroids significantly reduced, and anemia was improved, hormone levels decreased, but the recurrence rate. Conclusion Mifepristone can be used as a conservative treatment of uterine fibroids.